COVAX Alliance will allow distribution of vaccines to countries with less resources to buy them, making possible first deliveries of vaccines in 18 countries, including Cape Verde.
Under the COVAX initiative Cape Verde will receive 108,000 doses of the AstraZeneca/Oxford vaccine and 5,850 doses of Pfizer / BioNtech, according to the indicative distribution map released aiming to receive the first doses by end of February.
Frontline healthcare professionals will benefit from this first wave of vaccines with doses expected to be sufficient for about 3.3% of the total population of 145 countries out of about 190 participating in the Alliance, according to the interim distribution plan for the 1.2 million vaccines.
The 18 countries that will receive BioNTech / Pfizer vaccines in the initial phase includes: Bhutan, Bolivia, Bosnia, Cape Verde, Colombia, El Salvador, Georgia, Maldives, Mongolia, Peru, Philippines, South Korea, Rwanda, South Africa, Tunisia , Ukraine and the Palestinian territories.
Choice of these countries was made considering readiness to start vaccination plans, with priority five to those countries which not yet started their vaccination program and where healthcare professionals are most exposed to high transmission of covid19.
COVAX is one of three pillars of the Access to COVID-19 Tools (ACT) Accelerator, which was launched in April 2020 by the World Health Organization (WHO), the European Commission and France in response to this pandemic.